NEW YORK (GenomeWeb News) – Microfluidics firm Dolomite today said it has licensed microdroplet generation technology IP from the Japan Science and Technology Agency.

The deal covers patent families WO2002/068104 and WO2005/089921, and as part of the agreement, Dolomite can sublicense the technology. Licenses are issued on a per-chip basis and are available in any quantity. Dolomite customers can purchase and use Dolomite droplet chips for R&D.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.